Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab

Published:2020-08-17 Issue:10 Volume:59 Page:1294-1295
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Criado Paulo R.¹²,Criado Roberta F. J.¹²,Pincelli Thais P.³,Yoshimoto Thais A.¹,Naufal Gabriela G. A.¹,Abdalla Beatrice M. Z.¹^ORCID

Affiliation:

1. Dermatology Department Centro Universitário Saúde ABC (Faculdade de Medicina do ABC)An UCARE Center Santo André Brazil

2. Alergoskin Alergia e DermatologiaAn UCARE Center Santo André Brazil

3. Dermatology Department Mayo Clinic Jacksonville Florida USA

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.15134

Reference5 articles.

1. Association between urticaria and virus infections: A systematic review

2. Urticaria associated with Norovirus infection: Report of two cases

3. Early Insights into Immune Responses during COVID-19

4. Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria

5. Mast cells contribute to coronavirus‐induced inflammation: new anti‐inflammatory strategy;Kritas SK;J Biol Regul Homeost Agents,2020

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial;Open Forum Infectious Diseases;2024-02-23

2. Is Omalizumab Treatment Used During the COVID-19 Pandemic Effective on the Frequency and Severity of COVID-19?;Online Türk Sağlık Bilimleri Dergisi;2023-09-06

3. COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports;Dermatology Reports;2023-08-24

4. The Frequency and Severity of COVID-19 in Patients Receiving Biological Agents and Risk Factors: Experience of an Allergy Clinic;Asthma Allergy Immunology;2023-04-07

5. Omalizumab may protect allergic patients against COVID-19: A systematic review;World Allergy Organization Journal;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3